توقعات سوق علم الفيروسات في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب النوع (الاختبار التشخيصي، وتقنيات مكافحة العدوى الفيروسية، والعلاجات المضادة للفيروسات، والإنترفيرون)، والتطبيق (التهابات الجلد والأنسجة الرخوة، والتهابات الجهاز التنفسي، والتهابات الجهاز الهضمي والأمراض المنقولة جنسيًا، وعدوى المسالك البولية، وغيرها)، والمستخدم النهائي (المستشفيات، ومختبرات التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، والمعاهد البحثية والأكاديمية)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Virology Market – By Type

1.3.2        MEA Virology Market – By Application

1.3.3        MEA Virology Market – By End User

1.3.4        MEA Virology Market– By Country

2.           MEA Virology Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Virology Market– Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Virology Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Viral Infectious Diseases

5.1.2        Increasing Product Launches

5.2         Market Restraints

5.2.1        Availability of Alternative Products and High Price of Production of Products

5.3         Market Opportunities

5.3.1        Major Growth Potential in Emerging Economies

5.4         Future Trends

5.4.1        Continuous Requirement for Cost-Effective Products

5.5         Impact Analysis

6.           Virology Market– MEA Analysis

6.1         MEA Virology Market Revenue Forecast and Analysis

7.           MEA Virology Market Analysis – By Type

7.1         Overview

7.2         MEA Virology Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Test

7.3.1        Overview

7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1          Overview

7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1          Overview

7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Others

7.3.2.3.1          Overview

7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Viral Infection Controlling Techniques

7.4.1        Overview

7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          Active Prophylaxis

7.4.2.1.1          Overview

7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2          Passive Prophylaxis

7.4.2.2.1          Overview

7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Antiviral Therapeutics

7.5.1        Overview

7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          Virucidal Agents

7.5.2.1.1          Overview

7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2          Antiviral Agents

7.5.2.2.1          Overview

7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3          Immunomodulators

7.5.2.3.1          Overview

7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Interferons

7.6.1        Overview

7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.           MEA Virology Market Analysis – By Application

8.1         Overview

8.2         MEA Virology Market, by Application 2021 & 2028 (%)

8.3         Skin and Soft Tissue Infections

8.3.1        Overview

8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Respiratory Tract Infections

8.4.1        Overview

8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         GI Tract Infections

8.5.1        Overview

8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Sexually Transmitted Diseases

8.6.1        Overview

8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.           MEA Virology Market Analysis – By End User

9.1         Overview

9.2         MEA Virology Market Revenue Share, by End User (2021 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Diagnostic Laboratories

9.4.1        Overview

9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pharmaceutical and Biotechnological Companies

9.5.1        Overview

9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Research and Academic Institutes

9.6.1        Overview

9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.        MEA Virology Market – Country Analysis

10.1.1     Overview

10.1.2     Middle East & Africa: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1       Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1    Saudi Arabia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2    Saudi Arabia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3    Saudi Arabia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3       Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4       Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2       UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       UAE Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1    UAE: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2    UAE: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3    UAE: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3       UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4       UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3       South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1    South Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2    South Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3    South Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3       South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4       South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4       Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1    Rest of Middle East and Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2    Rest of Middle East and Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3    Rest of Middle East and Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3       Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4       Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact of COVID-19 Pandemic on MEA Virology Market

11.1      Overview

12.        MEA Virology Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Johnson and Johnson Services, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      F. HOFFMANN-LA ROCHE LTD.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      QIAGEN

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Illumina, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      GlaxoSmithKline Plc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      AbbVie Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Gilead Sciences, Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             MEA Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Virology Market, By Type – Revenue and Forecast to 2028(USD Million)

Table 9.             UAE Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11.          UAE Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12.          UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          South Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16.          South Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17.          South Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18.          South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Middle East and Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Middle East and Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Middle East and Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done by Companies

Table 27.          Inorganic Developments Done by Companies

Table 28.          Glossary of Terms, Virology Market

Figure 1.           MEA Virology Market Segmentation

Figure 2.           MEA Virology Segmentation, By Country

Figure 3.           MEA Virology Market Overview

Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in MEA Virology Market

Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in MEA Virology Market

Figure 6.           South Africa to Show Significant Growth During Forecast Period

Figure 7.           MEA PEST Analysis

Figure 8.           MEA Virology Market: Impact Analysis of Drivers and Restraints

Figure 9.           MEA Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        MEA Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11.        MEA Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        MEA DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        MEA Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        MEA Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        MEA Virology Market, by Application 2021 & 2028 (%)

Figure 24.        MEA Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        MEA Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        MEA Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        MEA Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31.        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Middle East and Africa: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36.        Middle East & Africa: Virology Treatment Market, by Country, 2021 & 2028 (%)

Figure 37.        Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        UAE: Virology Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Impact of COVID-19 Pandemic on Virology Market in MEA Countries

1. Abbott
2. AbbVie Inc.
3. F. Hoffmann-La Roche Ltd.
4. Gilead Sciences, Inc.
5. GlaxoSmithKline Plc
6. Illumina, Inc.
7. Johnson and Johnson Services, Inc.
8. QIAGEN
9. Siemens AG
10. Thermo Fisher Scientific Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Virology market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the MEA Virology market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution